The immune-cell origin of hematologic malignancies provides a unique avenue for the
understanding of both the mechanisms of immune responsiveness and immune escape …

The field of immunotherapy in cancer treatments has been accelerating over recent years
and has entered the forefront as a leading area of ongoing research and promising …

Haploidentical stem cell transplantation (haplo-SCT) achieves superior or at least
comparable clinical outcomes to HLA-matched sibling donor transplantation (MSDT) in …

Background This study compared the effects of pre-transplantation minimal residual disease
(pre-MRD) on outcomes in AML patients who underwent human leukocyte antigen-matched …

Background Previous reports suggest a benefit associated with haploidentical donor
transplantation (HIDT) compared to matched sibling donor transplantation (MSDT) in certain …

Graft‐versus‐host disease (GvHD) is an important complication that can be observed after
allogeneic hematopoietic stem cell transplantation (allo-HSCT). Acute GvHD (aGvHD) is …

Animal models have indicated that intestinal microbiota influence acute graft-versus-host
disease (aGVHD) by modulating immune homeostasis. But, in humans, the mechanism by …

Hematopoietic stem cell transplantation (HSCT) is a highly effective and unique medical
procedure for the treatment of most hematological malignancies. The first allogeneic …

This study evaluated the effects of pretransplantation minimal residual disease (pre‐MRD)
on outcomes of patients with acute lymphoblastic leukemia (ALL) who underwent …

We retrospectively investigated outcomes of haploidentical donor (HID) transplant for adults
with standard‐risk acute lymphoblastic leukaemia (ALL) in first complete remission (CR 1) …